CN103202789A - 一种植物源生发白转黑洗发剂及其制备方法 - Google Patents
一种植物源生发白转黑洗发剂及其制备方法 Download PDFInfo
- Publication number
- CN103202789A CN103202789A CN 201310149222 CN201310149222A CN103202789A CN 103202789 A CN103202789 A CN 103202789A CN 201310149222 CN201310149222 CN 201310149222 CN 201310149222 A CN201310149222 A CN 201310149222A CN 103202789 A CN103202789 A CN 103202789A
- Authority
- CN
- China
- Prior art keywords
- hair
- shampoo
- fructus
- kilogram
- hair growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002453 shampoo Substances 0.000 title claims abstract description 48
- 230000003779 hair growth Effects 0.000 title claims abstract description 41
- 230000001737 promoting effect Effects 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 210000004209 hair Anatomy 0.000 title abstract description 77
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 51
- 239000003814 drug Substances 0.000 claims abstract description 48
- 239000002994 raw material Substances 0.000 claims abstract description 41
- 210000000582 semen Anatomy 0.000 claims abstract description 32
- 240000007594 Oryza sativa Species 0.000 claims abstract description 26
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 26
- 230000001954 sterilising effect Effects 0.000 claims abstract description 22
- 238000000855 fermentation Methods 0.000 claims abstract description 19
- 230000004151 fermentation Effects 0.000 claims abstract description 19
- 238000009835 boiling Methods 0.000 claims abstract description 15
- 244000269722 Thea sinensis Species 0.000 claims abstract description 14
- 239000010495 camellia oil Substances 0.000 claims abstract description 12
- 235000009569 green tea Nutrition 0.000 claims abstract description 11
- 241000196324 Embryophyta Species 0.000 claims description 32
- 241000533849 Gleditsia Species 0.000 claims description 30
- 238000004659 sterilization and disinfection Methods 0.000 claims description 21
- 239000000463 material Substances 0.000 claims description 14
- 238000010298 pulverizing process Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 10
- 238000004062 sedimentation Methods 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 16
- 201000010099 disease Diseases 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 230000008901 benefit Effects 0.000 abstract description 8
- 241001116742 Drynaria Species 0.000 abstract description 3
- 244000286838 Eclipta prostrata Species 0.000 abstract description 3
- 244000276331 Citrus maxima Species 0.000 abstract description 2
- 235000001759 Citrus maxima Nutrition 0.000 abstract description 2
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 229930014626 natural product Natural products 0.000 abstract description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 230000006978 adaptation Effects 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract 1
- 235000009566 rice Nutrition 0.000 abstract 1
- 229930182490 saponin Natural products 0.000 abstract 1
- 150000007949 saponins Chemical class 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 21
- 201000004384 Alopecia Diseases 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 19
- 231100000360 alopecia Toxicity 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 15
- 210000003780 hair follicle Anatomy 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 13
- 230000037308 hair color Effects 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 210000004761 scalp Anatomy 0.000 description 9
- 235000016709 nutrition Nutrition 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000035764 nutrition Effects 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 206010049865 Achromotrichia acquired Diseases 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 235000013824 polyphenols Nutrition 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 235000013616 tea Nutrition 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 206010003694 Atrophy Diseases 0.000 description 4
- 208000004631 alopecia areata Diseases 0.000 description 4
- 230000037444 atrophy Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 241000201295 Euphrasia Species 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 239000003098 androgen Substances 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003648 hair appearance Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 208000008742 seborrheic dermatitis Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 241000931143 Gleditsia sinensis Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010072045 Radiation alopecia Diseases 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 241000001522 Terminalia chebula Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 206010047642 Vitiligo Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229940030486 androgens Drugs 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229930185884 camellianin Natural products 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000002768 hair cell Anatomy 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 2
- 229940052490 naringin Drugs 0.000 description 2
- 229930019673 naringin Natural products 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 240000002930 Alternanthera sessilis Species 0.000 description 1
- 235000015579 Alternanthera sessilis Nutrition 0.000 description 1
- 206010003225 Arteriospasm coronary Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000054262 Cassytha capillaris Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 241000480045 Citrus suavissima Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 208000003890 Coronary Vasospasm Diseases 0.000 description 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 244000241463 Cullen corylifolium Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 244000147058 Derris elliptica Species 0.000 description 1
- 241000282807 Diceros bicornis Species 0.000 description 1
- 241000431990 Drynaria sinica Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001013248 Eulepidotis folium Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241001446187 Kermes Species 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000222065 Lycoperdon Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 206010027145 Melanocytic naevus Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241000431987 Neocheiropteris fortunei Species 0.000 description 1
- 208000007256 Nevus Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000751897 Paederus Species 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000293846 Polygonatum multiflorum Species 0.000 description 1
- 241000768494 Polymorphum Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101710092601 Protein 7.3 Proteins 0.000 description 1
- 240000001619 Prunus glandulosa Species 0.000 description 1
- 235000018992 Prunus glandulosa Nutrition 0.000 description 1
- 235000013999 Prunus japonica Nutrition 0.000 description 1
- 241001446509 Psoralea Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- CIOAGBVUUVVLOB-NJFSPNSNSA-N Strontium-90 Chemical compound [90Sr] CIOAGBVUUVVLOB-NJFSPNSNSA-N 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 240000000920 Typhonium flagelliforme Species 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000012824 chemical production Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 201000011634 coronary artery vasospasm Diseases 0.000 description 1
- 208000002528 coronary thrombosis Diseases 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000000550 effect on aging Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000010336 energy treatment Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003370 grooming effect Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 210000000442 hair follicle cell Anatomy 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- CXORMDKZEUMQHX-UHFFFAOYSA-N kermesic acid Chemical compound O=C1C2=C(O)C(O)=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C CXORMDKZEUMQHX-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000024241 parasitism Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种植物源生发白转黑洗发剂及其制备方法,原料组份及重量份数为:何首乌0.4-0.5份、旱莲草0.3-0.5份、皂角0.3-0.5份、菟丝子0.3-0.5份、补骨脂0.4-0.5份、骨碎补0.4-0.5份、山楂0.2-0.3份、糯米0.2-0.3份和山泉水40-50份或/和山茶油0.3-1.0份、柚子皮0.2-0.3份、绿茶0.2-0.3份。本洗发剂的制备方法,是将各中药原料经粗粉碎,煮沸杀菌,控制温度为18-22℃自然发酵沤制50-60天制备得到。本产品为纯天然制品,实现内病外治,表本兼治,对人安全可靠,无毒,无副作用。药源广泛,价格便宜,配制简单,疗效快,适用症广泛,使用方便,安全可靠,不污染环境,很适合工业化规模生产,具有较好经济效益、社会效益和生态效益。
Description
技术领域
本发明属于日用化工和护发技术领域,涉及一种植物源生发白转黑洗发剂及其制备方法。
背景技术
头发是人体组织的一部份,是由细胞所组成的有机体。头发细胞是从毛囊内分裂,以倍数增加,新生头发就会从毛囊推向头皮表面。头发每天脱落30条以下是正常的新陈代谢征状,每个头发毛囊在一年内使会生出新头发。有一头乌黑的头发使人显得年轻、健康和精神,因此人们都希望自己拥有一头自然生长的黑发。随着社会的发展,生活节凑的加快,人们的工作、生活压力也越来越大,免疫力也随之下降,头发白和掉头发的也越来越多。头发过多脱落或变白的原因很多,与人体功能减退密切相关,同时与遗传、精神紧张、用脑过度、营养不良等密切相关。中医认为,忧伤郁闷,会致肝肾与脾俱伤、营血失调,使头发失其营养,这样头发变白或脱落就在所难免。长期缺少头发生长所必需的主要原料20多种氨基酸,以及头发形成所必需的维生素及微量元素等均可造成脱发。精神因素对脱发的影响也不应忽视,人在长期精神情绪紧张后可出现脱发。如果头发缺乏必须的活性蛋白质即毛发细胞生长蛋白,头发便会在每次更新替换后逐渐萎缩,渐渐由粗变幼,由幼长变幼短,再变成幼而细,萎缩直至白绒毛,形成日常所见的秃头症状。人体内部的油脂随着汗泉腺带到头部分沁过多,会堵塞毛孔的疏通,压迫周围毛细血管扩张,使毛囊细胞萎缩,无法正常生发。另是由于毛囊吸收化学品过多,破坏毛囊黑色素的吸收使黑发变白。
实验证明,毛发生长关键在毛囊内的每个细胞,细胞只要有合适条件充足养份,任何细胞都可利用分裂而达到重生。若能提供必须的生长的活性蛋白来滋养头发毛囊内的细胞,细胞就会自然分裂,以倍数增加,新生头发就会出生。在现有技术中,用于养发护发的产品通常为洗发液、调理护发精华素及护发素,只能起到护发的作用,不能从根本上改善头发毛囊内的细胞,因而头发再生和白转黑难以实现。随着人们生活水平的提高,对有化学品制备的生发剂因其具有副作用和局限性,而逐渐被淘汰。为此,人们发明了以口服或外用的药剂来促进毛发的再生。现将检索有关技术摘录如下:
中国专利CN200580000121.5,一种白发转生黑发的乌发液制剂及制备方法;由下列组分重量配比组成:冬虫草10~14.5、人参1~30、黄蓖1~20、芦荟1~30、田三七1~15、当归1~10、丹参1~10、透骨草1~14、白鲜皮1~9、菟茧丝子1~20、芜活2~9、木瓜1~10、苦参1~9、防风1~9.5、荆芥1~9、骨碎补1~9、首乌1~30、侧柏叶1~30、早莲草1~30和白芍1~9。
中国专利CN200310112149.0,一种黑发生发保健药物及制备工艺。该发明的配方组成及配比(百分重量):中草药复合萃取物a+b:20~60%、天然维生素A0.3~15%、丝肽0.3~15%、酪氨酸0.5~10%、胱氨酸0.5~10%和辅料:10~30%。其中中草药复合萃取物a+b的配比(百分重量):首乌5~25%、核桃5~25%、人参3~15%、田七3~15%、当归3~15%、槐角3~15%、旱莲草5~25%、山朱萸3-15%、黑芝麻5~25%、胡麻仁4~20%、女贞子3~15%、丹参3~15%、牛七3~15%、桂枝3~15%、川椒3~15%、桃仁3~15%、黑蚁3~15%和黑阳参3~15%。
中国专利CN200510019389.5,一种防脱发生发激活素,该激活素由原料重量百分比:非那雄胺5~10%、何首乌20~30%、侧柏叶30~40%、维生素B6 1~5%和大蒜20~40%。
中国专利CN200510020229.2,速效生发液。该生发液组份及重量份:何首乌150~300份、樟脑30~50份、官桂30~50份、诃子100~150份、熟地150~180份、甘草80~120份和芝麻油2500~3000。
中国专利CN201010104214.5,一种由多种植物制成的黑发养发冰泥及其制备方法。其组份及重量份:何首乌10~30份、五倍子10~30份、桑甚子515份、生地黄5~15份、墨草莲10~30份和乌梅10~30份。
中国专利CN201010511028.3,一种养发乌发的组合物。其组合物总重量为:天山雪莲5~40%,红蚂蚁5~40%,拐枣5~40%和白酒50~80%。
中国专利CN200810167825.7,生发毛囊注射液。技术方案:所用原料组份及重量份数为:丹参10~20份、川乌10~20份、红花30~50份、补骨脂50~60份、何首乌100~200份、桑甚子100~200份、当归50~100份、川芎50~80份、桃仁50~60份、樟脑60~70份、官桂80~100份、诃子60~90份、熟地100~150份、甘草100~150份和侧柏叶200~300份十五种中药。
本发明人根据传统中医学“肝为肾之母,发为血之余”肾藏精,肝造血,精血同源相互转化,两者缺一不可的理论,探明人的毛发与肌肤的健康状况与血液之间的关系密不可分,毛发乌黑柔润有赖于精血的营养。正常人在年少时气血充盈,皮肤幼嫩光滑头发茂密且乌黑光亮;若过度疲劳、饮食不良、睡眠不足、精神压力过大都容易导致肝肾两虚气血不足,全身的血液循环疲软,令人头昏目眩,皮肤干燥枯黄,造成头发的发质变差,容易出现早白和脱落。本发明人结合本地区侗族民间利用植物源生发及白发转黑发的配方和制备方法,经过长期大量摸索总结,制备出一种见效快、无副作用、表本兼治的植物源生发白转黑洗发剂及其制备方法。
发明内容
本发明的目的:针对男性脂溢型脱发、斑秃、女性雄激素脱发、癌症放疗脱发、肝硬化脱发,由于精神压力大所引起脱发,以及其它各种原因引起的白发、脱发诸症之病因、病机及特点,以及市场上治疗脱发、白发药物的疗效均不理想,见效较慢,且易反复的缺点,根据传统中医学理论,结合本地区侗族民间利用植物源生发及白发转黑发的配方和制备方法,采用内病外治的方案,经过多年临床经验,提供一种见效快、无副作用、表本兼治,疗效更好的植物源生发白转黑洗发剂;本发明的另一目的是提供该洗发剂的制备方法。
本发明的是这样实现的:
一种植物源生发白转黑洗发剂,其原料组份及重量份数为:何首乌0.4-0.5份、旱莲草0.3-0.5份、皂角0.3-0.5份、菟丝子0.3-0.5份、补骨脂0.4-0.5份、骨碎补0.4-0.5份、山楂0.2-0.3份、糯米0.2-0.3份和山泉水40-50份。
以上所述的植物源生发白转黑洗发剂,其原料组份及重量份数为:何首乌0.5份、旱莲草0.4份、皂角0.4份、菟丝子0.5份、补骨脂0.5份、骨碎补0.4份、山楂0.2份、糯米0.3份和山泉水45份。
一种植物源生发白转黑洗发剂,其原料组份及重量份数为:何首乌0.3-0.4份、旱莲草0.3-0.4份、皂角0.3-0.4份、菟丝子0.3-0.4份、补骨脂0.3-0.4份、骨碎补0.3-0.4份、山楂0.2-0.3份、柚子皮0.2-0.3份、绿茶0.2-0.3份、糯米0.2-0.3份和山泉水45-50份。
一种植物源生发白转黑洗发剂,其原料组份及重量份数为:何首乌0.4-0.5份、旱莲草0.4-0.5份、皂角0.4-0.5份、菟丝子0.4-0.5份、补骨脂0.4-0.5份、骨碎补0.4-0.5份、山楂0.2-0.3份、糯米0.2-0.3份、山茶油0.3-1.0份和山泉水45-50份。
以上任何一项所述的植物源生发白转黑洗发剂的制备方法,包括将各中药原料经粗粉碎,杀菌,沤制,过滤工序,制备得到植物源生发白转黑洗发剂,具体工艺步骤是如下:
(1)粗粉碎:将何首乌0.4-0.5份、旱莲草0.3-0.5份、皂角0.3-0.5份、菟丝子0.3-0.5份、补骨脂0.4-0.5份、骨碎补0.4-0.5份、山楂0.2-0.3份或/和柚子皮0.2-0.3份、绿茶0.2-0.3份中药原料分别用粉碎机粉碎,过40-100目筛,或者用切片机切碎备用;
(2)杀菌:将全部粗粉碎的中药原料加入锅中,加山泉水15-20份,加热至沸备用;
(3)沤制:将经步骤(2)杀菌的中药原料加入坛中,加山泉水25-35份,再加入糯米0.2-0.3份或/和山茶油0.3-1.0份,盖上水封盖水封,置于阴凉的工房或洞穴中,自然发酵沤制50-60天,中药原料自然沉淀后进入下一工序;
(4)过滤:将沤制发酵液用纱布或工业滤布过滤,得到植物源生发白转黑洗发剂。
以上所述的植物源生发白转黑洗发剂的制备方法,所述的自然发酵沤制控制温度为18-22℃,控制水封盖水位,当坛内有压力时,打开水封盖平衡气压,再盖上水封盖。
本发明植物源生发白转黑洗发剂使用时,将患者的头发用水洗湿,然后将洗发剂涂搽头皮头发,洗发剂用量以涂匀头发头皮为准,用手擦洗5-10分钟,再用手按摩15-20分钟,最后用清水冲洗干净。每隔2-3天用本洗发剂洗发一次。本植物源生发白转黑洗发剂,可作治疗或长期护发使用。适用于男性脂溢型脱发、斑秃、女性雄激素脱发、癌症放疗脱发、肝硬化脱发、精神压力大引起脱发白发,以及其它各种原因引起的白发、脱发。使用本洗发剂期间不宜染发和烫发。
以下是本洗发采用原药的药理药性:
(1)何首乌(P.multiflorum),别名:首乌、赤首乌、地精、赤敛和陈知白。功效:补肝益肾、固精缩尿、养血、强筋益髓、祛风和明目。何首乌性温,含有构成脑脊髓、血细胞和细胞膜所必需的原料卵磷脂,营养脑神经,能够滋养头发,促使头发黑色素生成,赋予秀发深层营养,使秀发强韧不易折断,营养头发,使头发乌黑发亮,能缓减人体动脉粥样硬化。《开宝本草》云:“益气血,黑髭鬓,悦颜色,久服长筋骨,益精髓,延年不老。”
(2)旱莲草(Herba Ecliptae Eclipta prostrala L.),别名:金陵草、莲子草和旱莲子。旱莲草墨旱莲味甘、酸,性凉;归肾、肝经;具有调节免疫、抑菌、凉血、止血、滋补肝肾,乌须固齿和乌发生发功效。主治:肝肾不足、眩晕耳鸣、视物昏花、腰膝酸软、发白齿摇、劳淋带浊、吐血、咳血、衄血、尿血、便血、血痢、刀伤出血、须发早白、白喉、淋浊、带下、阴部湿痒和老鼠痣。
(3)皂角(Gleditsia sinensis Lam),别名:皂角子、鸡栖子、皂角、大皂荚、长皂荚、长皂角、大皂角、悬刀、乌犀。皂角性味温;辛、咸;归肺经、大肠经;小毒;具有祛痰止咳、开窍通闭、杀虫散结的功效;主治痰咳喘满、中风口噤、痰涎壅盛、神昏不语、癫痫、
喉痹、二便不通、痈肿疥癣。皂角皮是天然的工业洗涤产品,可用于动物毛皮制品的清洗加工,加工后毛皮具有毛皮柔软、光泽好。
(4)菟丝子(Semen Cuscutae Chinensis),别名:无根草、黄丝、黄藤子、豆寄生。丝子味甘,温;归肝、肾、脾经。具有滋补肝肾、固精缩尿、安胎、养肝明目、止泻、抑制肠运动、兴奋子宫、并能增强非特异性抵抗力等。主治用于阳痿遗精、尿有余沥、遗尿尿频、腰膝酸软、目昏耳鸣、肾虚胎漏、胎动不安、脾肾虚泻、外治白癜风。
(5)补骨脂(Malaytea Scurfpea Fruit),别名:骨脂、故子、故脂子、故之子。补骨脂味辛、苦;性温;归肾、心包、脾、胃、肺经。具有补肾助阳、纳气平喘、温脾止泻功能。主治肾阳不足、下元虚冷、腰膝冷痛、阳痿遗精、尿频、遗尿、肾不纳气、虚喘不止、脾肾两虚、大便久泻,外用于白癜风、斑秃、银屑病。
(6)骨碎补[Drynaria fortunei(Kunze)J.Smith[Polypadium fortunei Kunze],别名:石岩姜、猴姜、毛姜、申姜、爬岩姜、岩连姜。味苦,性温;归肾、肝经。具有补肾强骨,续伤止痛功能。用于肾虚腰痛、耳鸣耳聋、牙齿松动、跌扑闪挫、筋骨折伤;外治斑秃、白癜风。
(7)山楂(Crataegus pinnatifida),别名:棠球子、红果、大山楂、山里红、山里果、赤枣子、鼠查、赤瓜实、酸查、胭脂果。性味微温,甘、酸。具有健胃消食、活血化瘀功能。
(8)柚子皮(Citrus grandis(L.)Osbecd),别名:气柑皮、橙子皮、五爪红、化橘红。性味辛、甘、苦,温;归脾、肾、膀胱经。具有宽中理气;消食;化痰;止咳平喘功能。主治气郁胸闷;脘腹冷痛;食积;泻痢;咳喘;疝气。新鲜柚子含类胰岛素、柚皮甙、新橙皮甙、挥发油、维生素B1、维生素B2、烟酸、维生素C、果糖、葡萄糖、蛋白质、脂类、铁、钙、磷及粗纤维等成分。柚皮苷具有抗炎、抗病毒、抗癌、抗突变、抗过敏、抗溃疡、镇痛、降血压活性,能降血胆固醇、减少血栓的形成,改善局部微循环和营养供给,可用于生产防治心脑血管疾病。
(9)绿茶,绿茶含有机化合物450多种、无机矿物质15种以上,具有药理作用的主要成份是茶多酚、咖啡碱、脂多糖、茶氨酸等。茶多酚具有很强的抗氧化性和生理活性,有阻断脂质过氧化反应,清除活性酶的作用,是人体自由基的清除剂。据日本奥田拓勇试验结果,证实茶多酚的抗衰老效果要比维生素E强18倍。茶叶不仅具有提神清心、清热解暑、消食化痰、去腻减肥、清心除烦、解毒醒酒、生津止渴、降火明目、止痢除湿等药理作用,还对现代疾病,如锶90和钴60辐射病、心脑血管病、癌症等疾病,有一定的药理功效。茶多酚是水溶性物质,有助于美容护肤,能清除肌肤的油腻、消毒、灭菌、抗皮肤老化,减少日光中的紫外线辐射对皮肤的损伤,对防衰老、防癌、抗癌、杀菌、消炎等均有特殊效果。
(10)山茶油(kamellia oleifela abel),别名:野山茶油,茶籽油,油茶籽油,取自油茶树的种籽,是中国的特产。山茶油中不饱和脂肪酸高达90%以上,油酸达到80-83%,亚油酸达到7-13%,含有生理活性成分角鲨烯,有很好的富氧能力,可抗缺氧和抗疲劳,提高人体免疫力,增进胃肠道的功能,而且都含有丰富的维生素E、维生素D、维生素K和b-胡萝卜素(维生素A原)。茶油中还含有橄榄油所没有的特定生理活性物质如山茶甙、山茶皂甙、茶多酚等,其中山茶甙有强心作用,山茶皂甙有溶血栓作用,能防治血管硬化所致的多种心脑血管疾病,也是护肤护发珍品。
(11)糯米(Semen Oryzae Glutinosae),糯米含有蛋白质、脂肪、糖类、钙、磷、铁、维生素B1、维生索B2、烟酸及淀粉等,每100克糯米的营养成分:能量348千卡;蛋白质7.3克;脂肪1克;碳水化合物78.3克;叶酸18.7微克;膳食纤维0.8克;硫胺素0.11毫克;核黄素0.04毫克;烟酸2.3毫克;维生素E1.29毫克;钙26毫克;磷113毫克;钾137毫克;钠1.5毫克;镁49毫克;铁1.4毫克;锌1.54毫克;硒2.71微克;铜0.25毫克;锰1.54毫克。性味甘;温;入脾、胃、肺经。具有中益气、健脾暖胃、固表止汗功能。主治脾胃虚寒、反胃、食少、泄泻、痘疮、多汗等。
本发明的优点和积极效果:
本发明的植物源生发白转黑洗发剂组方科学合理,具有滋阴补肾、黑发明目、防治疾病和延缓衰老的功能。能改善脏腑功能,滋补肝肾,养血乌发,迅速激活酪氨酸酶,使白发逐渐由白变黑。通过渗透、清理、补充、供养定位直接施治血管、毛囊和毛发,使皮层血液粘度下降,促使血管扩张,预防血小板聚集、冠状动脉痉挛和血栓形成,从而起到清理及畅通血管的作用,能增强头皮毛细血管的血流量,增加血管对寒冷的抵抗力,维持毛细血管的正常通透性;药物可透过头皮被吸收,促进细胞生长,延缓头发、皮肤的萎缩和退化,加速多种损伤的康复,能直接对抗各种因素引起的脱发,养精气,长发,治须发早白;增强免疫功能,益血则发华,肾气足则齿坚而发眉长,长毛发。通过多味中药共同作用,平衡头皮油脂分泌,增强毛发营养,以养发为根本,有效地恢复毛囊活力,促进毛发浓密生长,不仅能对抗造成脱发的雄激素,而且能改善头皮营养供应、刺激头发生长,使新生发质量明显提高,浓密又坚韧,乌黑亮丽,有效解决脱发、枯黄和白发等问题。
本产品为纯天然制品,实现内病外治,表本兼治,对人安全可靠,无毒,无副作用。药源广泛,价格便宜,配制简单,疗效快,适用症广泛,使用方便,安全可靠,不污染环境,很适合工业化规模生产,具有较好经济效益、社会效益和生态效益。
具体实施方式
下面结合实施例,进一步阐述本发明。应当理解这些实施例仅用于说明本发明,而不是用于限制本发明的范围。
(一)制备实施例
实施例1
原料组份及重量数为:
何首乌0.5公斤、旱莲草0.4公斤、皂角0.4公斤、菟丝子0.5公斤、补骨脂0.5公斤、骨碎补0.4公斤、山楂0.2公斤、糯米0.3公斤、山茶油0.8公斤和山泉水45公斤。
制备方法:
将何首乌0.5公斤、旱莲草0.4公斤、皂角0.4公斤、菟丝子0.5公斤、补骨脂0.5公斤、骨碎补0.4公斤、山楂0.2公斤中药原料分别用粉碎机粗粉碎,过40目筛;将全部粗粉碎的中药原料加入锅中,加山泉水15份,加热至沸杀菌;将经杀菌的中药原料加入坛中,加山泉水30公斤,再加入糯米0.3公斤和山茶油0.5公斤,盖上水封盖加水水封,置于阴凉的工房内,控制温度18-22℃,控制水封盖水位,当坛内有压力时,打开水封盖平衡气压,再盖上水封盖。中药原料自然沉淀,自然发酵沤制60天;将沤制发酵液用纱布,得到植物源生发白转黑洗发剂。
实施例2
原料组份及重量数为:
何首乌0.45公斤、旱莲草0.3公斤、皂角0.4公斤、菟丝子0.4公斤、补骨脂0.45公斤、骨碎补0.45公斤、山楂0.25公斤、糯米0.25公斤、山茶油1公斤和山泉水40公斤。
制备方法:
将何首乌0.45公斤、旱莲草0.3公斤、皂角0.4公斤、菟丝子0.4公斤、补骨脂0.45公斤、骨碎补0.45公斤、山楂0.25公斤中药原料分别用粉碎机粗粉碎,过80目筛;将全部粗粉碎的中药原料加入锅中,加山泉水15份,加热至沸杀菌;将经杀菌的中药原料加入坛中,加山泉水25公斤,再加入糯米0.25公斤和山茶油1公斤,盖上水封盖加水水封,置于阴凉的工房内,控制温度18-22℃,控制水封盖水位,当坛内有压力时,打开水封盖平衡气压,再盖上水封盖。每隔10天翻动中药原料一次,自然发酵沤制50天,中药原料自然沉淀;将沤制发酵液用工业滤布过滤,得到植物源生发白转黑洗发剂。
实施例3
原料组份及重量数为:
何首乌0.4公斤、旱莲草0.5公斤、皂角0.3公斤、菟丝子0.3公斤、补骨脂0.4公斤、骨碎补0.5公斤、山楂0.3公斤、糯米0.2公斤和山泉水50公斤。
制备方法:
将何首乌0.4公斤、旱莲草0.5公斤、皂角0.3公斤、菟丝子0.3公斤、补骨脂0.4公斤、骨碎补0.5公斤、山楂0.3公斤中药原料分别用粉碎机粗粉碎,过100目筛;将全部粗粉碎的中药原料加入锅中,加山泉水20公斤,加热至沸杀菌;将经杀菌的中药原料加入坛中,加山泉水30公斤,再加入糯米0.2公斤,盖上水封盖加水水封,置于阴凉的工房内,控制温度18-22℃,控制水封盖水位,当坛内有压力时,打开水封盖平衡气压,再盖上水封盖。自然发酵沤制55天,中药原料自然沉淀;将沤制发酵液用纱布过滤,得到植物源生发白转黑洗发剂。
实施例4
原料组份及重量数为:
何首乌0.5公斤、旱莲草0.5公斤、皂角0.4公斤、菟丝子0.3公斤、补骨脂0.4公斤、骨碎补0.4公斤、山楂0.2公斤、糯米0.25公斤和山泉水46公斤。
制备方法:
将何首乌0.5公斤、旱莲草0.5公斤、皂角0.4公斤、菟丝子0.3公斤、补骨脂0.4公斤、骨碎补0.4公斤、山楂0.2公斤中药原料分别用粉碎机粗粉碎,过60目筛;将全部粗粉碎的中药原料加入锅中,加山泉水16公斤,加热至沸杀菌;将经杀菌的中药原料加入坛中,加山泉水30公斤,再加入糯米0.25公斤,盖上水封盖加水水封,置于阴凉的洞穴内,控制温度18-22℃,控制水封盖水位,当坛内有压力时,打开水封盖平衡气压,再盖上水封盖。自然发酵沤制60天,中药原料自然沉淀;将沤制发酵液用纱布过滤,得到植物源生发白转黑洗发剂。
实施例5
原料组份及重量数为:
何首乌0.4公斤、旱莲草0.3公斤、皂角0.3公斤、菟丝子0.3公斤、补骨脂0.4公斤、骨碎补0.4公斤、山楂0.2公斤、柚子皮0.3公斤、绿茶0.2公斤、糯米0.2公斤和山泉水50公斤。
制备方法:
将何首乌0.4公斤、旱莲草0.3公斤、皂角0.3公斤、菟丝子0.3公斤、补骨脂0.4公斤、骨碎补0.4公斤、山楂0.2公斤、柚子皮0.3公斤中药原料分别用切片机切碎;将全部切碎的中药原料和绿茶0.2公斤加入锅中,加山泉水20公斤,加热至沸杀菌;将经杀菌的中药原料加入坛中,加山泉水30公斤,再加入糯米0.2公斤,盖上水封盖加水水封,置于阴凉的洞穴内,控制温度18-22℃,控制水封盖水位,当坛内有压力时,打开水封盖平衡气压,再盖上水封盖。每隔10天翻动中药原料一次,自然发酵沤制55天,中药原料自然沉淀;将沤制发酵液用工业滤布过滤,得到植物源生发白转黑洗发剂。
实施例6
原料组份及重量数为:
何首乌0.3公斤、旱莲草0.4公斤、皂角0.4公斤、菟丝子0.4公斤、补骨脂0.3公斤、骨碎补0.3公斤、山楂0.3公斤、柚子皮0.2公斤、绿茶0.3公斤、糯米0.3公斤和山泉水45公斤。
制备方法:
将何首乌0.3公斤、旱莲草0.4公斤、皂角0.4公斤、菟丝子0.4公斤、补骨脂0.3公斤、骨碎补0.3公斤、山楂0.3公斤、柚子皮0.2公斤中药原料分别用切片机切碎;将全部切碎的中药原料和绿茶0.3公斤加入锅中,加山泉水15份,加热至沸杀菌;将经杀菌的中药原料加入坛中,加山泉水30公斤,再加入糯米0.3公斤,盖上水封盖加水水封,置于阴凉的工房内,控制温度18-22℃,控制水封盖水位,当坛内有压力时,打开水封盖平衡气压,再盖上水封盖。自然发酵沤制60天,中药原料自然沉淀;将沤制发酵液用纱布或工业滤布过滤,得到植物源生发白转黑洗发剂。
(二)试用实施例
试用病例1
盘先生,41岁,企业职员,因工作压力大,思虑过多,导致过早白发满头。自2010年4月21日起用本洗发剂洗发5-10分钟,再用手按摩15-20分钟,最后用清水冲洗干净,每隔2天洗发一次。使用6天后部分毛囊开始发生变化,使用3个月后大部分毛囊发生根本变化,头前额和头后部长出灰发,使用5个月后头的其它部位长出灰发,先长出的灰发部份变黑,全部毛囊发生根本变化,八个月长出了满黑发。
试用病例2
韦先生,公务员,35岁,在本洗发剂之前,头顶都基本掉光。自2011年11月6日起用本洗发剂洗发和按摩。使用1周后,头发就不脱了,用了20日之后,头发就陆陆续续地长出较细的毛发,2个月后大部分毛囊发生根本变化,头顶部长出较细灰发。使用3个月时头顶皮基本上被覆盖,部分灰发变黑变粗。使用4个月时已长满黑发,并停用本洗发剂。日前回访,黑发依旧长势良好,并无脱发现象。
试用病例3
钟先生,42岁,公司老板,因应酬及烟酒过多,同时因长期食用高脂高营养的食品从而形成偏胖体质,患有严重的脂溢性脱发、脂溢性皮炎,导致谢顶,两边头发稀疏。自2012年6月23日起用本洗发剂洗发和按摩,每天一次。使用1周后头皮痒,用了23日之后,部分头皮长出灰色较细的毛发,50天后大部分毛囊发生根本变化,头顶部长出较多细灰发。使用3个月时头顶皮基本上被覆盖,两边头皮长出较细灰发,先长出的灰发变黑变粗。使用4个月时已长满黑发。目前还在正常护发使用本洗发剂,发质油亮柔软,黑发长势很好,并无脱发现象。
试用病例4
黄女士,31岁,职员,产后脱发。自2011年9月12日起用本洗发剂洗发和按摩,每天一次。使用10天后头皮发痒,改每2天一次。用了26日之后,部分头皮长出灰色较细的毛发,2个月后大部分毛囊发生根本变化,长出较多灰色细毛发,原黑发变得油亮,且不脱发了。使用3个月时长出的灰发变黑变粗。使用4个月时毛囊发生根本变化,已长出满头黑发。目前还在正常护发使用本洗发剂,黑发油亮柔软,长势很好,并无脱发现象。
试用病例5
甘女士,53岁,教师。曾患乳腺癌,化疗后头发大把地掉。于2010年7月开始试用本洗发剂,每2天一次,使用8天后头皮发痒,用了26日之后,部分头皮长出灰色较细的毛发,2个月后大部分毛囊发生根本变化,长出较多灰色细毛发,原黑发变得油亮,且不脱发了。使用3个月时长出的灰发变黑变粗。使用5个月时毛囊发生根本变化,已长出满头黑发。目前还在正常护发使用本洗发剂,黑发油亮柔软,长势较好,并无脱发现象。
试用病例6
伍女士,40多岁,职工,常染发,头发干且有20-30%的白发。于2010年3月开始试用本洗发剂,每2天一次,使用10天后头皮发涨发痒,用了20日之后,部分头皮长出灰色较细的毛发,2个月后大部分毛囊发生根本变化,长出较多灰色细毛发,原白发变灰了。使用3个月时长出的灰发变黑变粗,部分白发变黑。使用5个月时毛囊发生根本变化。使用5个月时已长出满头黑发。目前还在正常护发使用本洗发剂,头发获得较充足的养分,黑发亮泽而柔软,长势较好,并无脱发现象。
试用病例7
黎女士,29岁,自述在上初中时白发不算多,等工作后,由于工作紧张,压力大,白发增多,然后染发,经常头皮发红,头又痒,掉发,有过敏现象,染白发已有7年多,白发占10-20%。于2010年6月开始试用本洗发剂,每2天一次,使用7天后头皮发涨发痒,用了23日之后,头皮长出灰色较细的毛发,部分白发变灰。试用2个月后,大部分毛囊发生根本变化,长出较多灰色细毛发,原白发变灰了。使用4个月时,长出的灰发变黑变粗,部分白发变黑。使用5个月时毛囊发生根本变化,灰发变黑发。使用6个月时长出满头黑发,且发质得到改善。目前还在正常护发使用本洗发剂,每3天一次,头发获得较充足的养分,黑发亮泽而柔软,长势较好,并无脱发现象。
Claims (6)
1.一种植物源生发白转黑洗发剂,其特征在于:原料组份及重量份数为:何首乌0.4-0.5份、旱莲草0.3-0.5份、皂角0.3-0.5份、菟丝子0.3-0.5份、补骨脂0.4-0.5份、骨碎补0.4-0.5份、山楂0.2-0.3份、糯米0.2-0.3份和山泉水40-50份。
2.根据权利要求1所述的植物源生发白转黑洗发剂,其特征在于:原料组份及重量份数为:何首乌0.5份、旱莲草0.4份、皂角0.4份、菟丝子0.5份、补骨脂0.5份、骨碎补0.4份、山楂0.2份、糯米0.3份和山泉水45份。
3.一种植物源生发白转黑洗发剂,其特征在于:原料组份及重量份数为:何首乌0.3-0.4份、旱莲草0.3-0.4份、皂角0.3-0.4份、菟丝子0.3-0.4份、补骨脂0.3-0.4份、骨碎补0.3-0.4份、山楂0.2-0.3份、柚子皮0.2-0.3份、绿茶0.2-0.3份、糯米0.2-0.3份和山泉水45-50份。
4.一种植物源生发白转黑洗发剂,其特征在于:原料组份及重量份数为:何首乌0.4-0.5份、旱莲草0.4-0.5份、皂角0.4-0.5份、菟丝子0.4-0.5份、补骨脂0.4-0.5份、骨碎补0.4-0.5份、山楂0.2-0.3份、糯米0.2-0.3份、山茶油0.3-1.0份和山泉水45-50份。
5.根据权利要求1-4任何一项所述的植物源生发白转黑洗发剂的制备方法,其特征在于:包括将各中药原料经粗粉碎,杀菌,沤制,过滤工序,制备得到植物源生发白转黑洗发剂,具体工艺步骤是如下:
(1)粗粉碎:将何首乌0.4-0.5份、旱莲草0.3-0.5份、皂角0.3-0.5份、菟丝子0.3-0.5份、补骨脂0.4-0.5份、骨碎补0.4-0.5份、山楂0.2-0.3份或/和柚子皮0.2-0.3份、绿茶0.2-0.3份中药原料分别用粉碎机粉碎,过40-100目筛,或者用切片机切碎备用;
(2)杀菌:将全部粗粉碎的中药原料加入锅中,加山泉水15-20份,加热至沸备用;
(3)沤制:将经步骤(2)杀菌的中药原料加入坛中,加山泉水25-35份,再加入糯米0.2-0.3份或/和山茶油0.3-1.0份,盖上水封盖水封,置于阴凉的工房或洞穴中,自然发酵沤制50-60天,中药原料自然沉淀后进入下一工序;
(4)过滤:将沤制发酵液用纱布或工业滤布过滤,得到植物源生发白转黑洗发剂。
6.根据权利要求5所述的植物源生发白转黑洗发剂的制备方法,其特征在于:所述的自然发酵沤制控制温度为18-22℃,控制水封盖水位,当坛内有压力时,打开水封盖平衡气压,再盖上水封盖。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310149222 CN103202789A (zh) | 2013-04-26 | 2013-04-26 | 一种植物源生发白转黑洗发剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310149222 CN103202789A (zh) | 2013-04-26 | 2013-04-26 | 一种植物源生发白转黑洗发剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103202789A true CN103202789A (zh) | 2013-07-17 |
Family
ID=48750350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201310149222 Pending CN103202789A (zh) | 2013-04-26 | 2013-04-26 | 一种植物源生发白转黑洗发剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103202789A (zh) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103920002A (zh) * | 2014-04-17 | 2014-07-16 | 方祎 | 一种生发素及其制备方法 |
| CN104490611A (zh) * | 2014-12-12 | 2015-04-08 | 安徽新华学院 | 一种天然养发泡腾颗粒或泡腾片及其制备方法 |
| CN104740586A (zh) * | 2015-04-16 | 2015-07-01 | 李红英 | 一种中药乌发剂及其制备方法 |
| CN105853291A (zh) * | 2016-05-13 | 2016-08-17 | 申向阳 | 一种中草药洗发水 |
| CN106265245A (zh) * | 2016-08-22 | 2017-01-04 | 杭州孝恒生物科技有限公司 | 一种生物酶养发洗发液及其制备方法 |
| CN107155764A (zh) * | 2017-05-10 | 2017-09-15 | 王立存 | 一种柑桔种植方法 |
| CN107349142A (zh) * | 2016-05-09 | 2017-11-17 | 广州市优品化妆品科技有限公司 | 一种净屑平衡中药洗发水及其制备方法 |
| WO2018032837A1 (zh) * | 2016-08-13 | 2018-02-22 | 谭华锋 | 一种生物酵素染发剂 |
| CN112773862A (zh) * | 2021-02-03 | 2021-05-11 | 黑龙江中医药大学附属第一医院(黑龙江中医药大学第一临床医学院) | 一种中药组合物及其制备方法和应用 |
| CN113081927A (zh) * | 2021-04-27 | 2021-07-09 | 福建俪萃缘生物科技有限公司 | 一种茶多酚洗发液及其制备方法 |
-
2013
- 2013-04-26 CN CN 201310149222 patent/CN103202789A/zh active Pending
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103920002A (zh) * | 2014-04-17 | 2014-07-16 | 方祎 | 一种生发素及其制备方法 |
| CN104490611A (zh) * | 2014-12-12 | 2015-04-08 | 安徽新华学院 | 一种天然养发泡腾颗粒或泡腾片及其制备方法 |
| CN104490611B (zh) * | 2014-12-12 | 2017-08-08 | 安徽新华学院 | 一种天然养发泡腾颗粒或泡腾片及其制备方法 |
| CN104740586A (zh) * | 2015-04-16 | 2015-07-01 | 李红英 | 一种中药乌发剂及其制备方法 |
| CN107349142A (zh) * | 2016-05-09 | 2017-11-17 | 广州市优品化妆品科技有限公司 | 一种净屑平衡中药洗发水及其制备方法 |
| CN105853291A (zh) * | 2016-05-13 | 2016-08-17 | 申向阳 | 一种中草药洗发水 |
| WO2018032837A1 (zh) * | 2016-08-13 | 2018-02-22 | 谭华锋 | 一种生物酵素染发剂 |
| CN106265245A (zh) * | 2016-08-22 | 2017-01-04 | 杭州孝恒生物科技有限公司 | 一种生物酶养发洗发液及其制备方法 |
| CN107155764A (zh) * | 2017-05-10 | 2017-09-15 | 王立存 | 一种柑桔种植方法 |
| CN112773862A (zh) * | 2021-02-03 | 2021-05-11 | 黑龙江中医药大学附属第一医院(黑龙江中医药大学第一临床医学院) | 一种中药组合物及其制备方法和应用 |
| CN112773862B (zh) * | 2021-02-03 | 2022-04-12 | 黑龙江中医药大学附属第一医院(黑龙江中医药大学第一临床医学院) | 一种中药组合物及其制备方法和应用 |
| CN113081927A (zh) * | 2021-04-27 | 2021-07-09 | 福建俪萃缘生物科技有限公司 | 一种茶多酚洗发液及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103202789A (zh) | 一种植物源生发白转黑洗发剂及其制备方法 | |
| CN101485831B (zh) | 一种乌发生发的中药组合物及其制备方法 | |
| CN102784295B (zh) | 一种改善女性更年期综合症的保健制剂配方及其制备方法 | |
| CN105997836A (zh) | 一种酵素洗发水及其配制方法 | |
| CN102845571B (zh) | 一种桑叶祛斑养颜茶及其制备方法 | |
| CN106236677A (zh) | 一种养发护发生发茶麸纯植物酵素洗发液及其制备方法 | |
| CN103382431A (zh) | 一种中草药十八子保健酒及其制备方法 | |
| CN105853291A (zh) | 一种中草药洗发水 | |
| CN104306450A (zh) | 一种应用于治疗人头秃顶的洗头药液 | |
| CN102579908B (zh) | 一种排毒清透养颜中药制剂 | |
| CN104208623A (zh) | 具有妇女产后强身作用的瑶族洗浴药物及其制备方法 | |
| CN103550721B (zh) | 具有降压安眠功效的中药组合物及含有该组合物的药枕 | |
| CN102274309B (zh) | 头发毛囊改造剂及其制备方法 | |
| CN105288597A (zh) | 一种治疗皮肤色素沉着的药物 | |
| CN105213279A (zh) | 一种消除萎缩纹的身体乳及其制备方法 | |
| CN104473250A (zh) | 一种山药饮料及其制备方法 | |
| CN104547622A (zh) | 一种治疗白内障的中药制剂及其制备方法 | |
| CN112656930A (zh) | 一种生发、乌发的中药洗发水及其制备方法 | |
| CN103920002A (zh) | 一种生发素及其制备方法 | |
| CN102113562A (zh) | 无花果黑芝麻生发乌发果珍及其制备方法 | |
| CN101518620B (zh) | 一种治疗斑秃的中药制剂 | |
| CN105194487A (zh) | 一种美白养颜中药组合物及其面膜和制备方法 | |
| CN104524494A (zh) | 一种中药组合物 | |
| CN104524479B (zh) | 一种治疗经前期综合征的中药组合物及其制备方法 | |
| CN105943490A (zh) | 一种生发营养液及其配制方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130717 |